Relapse of staphylococcal endocarditis after clindamycin therapy.
A 25-year-old black female heroin addict presented with Staphylococcus aureus endocarditis. Because of a history of penicillin allergy, therapy was gegun with cephalothin (Keflin); lack of clinical response led to the use of clindamycin. Response was excellent. After six weeks of treatment she was discharged well, only to return six days later with recurrent endocarditis. The organism, confirmed by sensitivity and phage typing, was identifcal to that causing the inital episode. This patient illustrates the apparent failure of clindamycin to eradicate a deep-seated intravascular infection with a sensitive organism.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D002981:Clindamycin / Q000494:pharmacology / Q000627:therapeutic use*; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D005260:Female; D006556:Heroin Dependence / Q000150:complications; D006801:Humans; D008826:Microbial Sensitivity Tests; D012008:Recurrence; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013210:Staphylococcus / Q000187:drug effects / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D002981:Clindamycin